Researchers from the National University of Singapore (NUS) have invented a new blood test known as Amplified Plasmonic Exosome (Apex), capable of detecting a molecule that indicates early-stage Alzheimer's disease...
26 June 2019 News
25 June 2019 News
C4X Discovery (C4XD) has partnered with UK-based biopharmaceutical company PhoreMost to accelerate the Parkinson’s Disease drug discovery pipeline.
20 June 2019 News
Changes to the serotonin system of the brain could act as a crucial early warning signal for Parkinson’s disease and may lead to the development of new screening tools for...
13 June 2019 Analysis
A rapidly aging global population is leaving health services facing a dementia time bomb. Simulating the effects of the disease in virtual reality may enhance carers understanding of how to...
4 June 2019 News
An at-home, medical-grade brain stimulation headset has launched in the UK. The system, which is partnered with a therapy app, offers an alternative to pharmacological treatment for depression.
28 May 2019 News
Non-invasive brain stimulation may help speed up and improve vision recovery for cortically blind patients following a stroke or similar brain injury.
27 May 2019 News
An artificial intelligence (AI) system has been used to detect a collective of genetic causes for autism spectrum disorder.
20 May 2019 Comment
In general, intracranial stenting is still performed in rare cases, but only when other forms of medical therapy have failed.
17 May 2019 Comment
Approval of ADHD neurostimulation device clears path for treatments of related neurological disorders
GlobalData estimated the global market value for neurostimulation devices to be over $4.5 billion in 2017 and projects exponential growth into the future.
1 May 2019 Comment
Axial motor symptoms are common in patients who live with Parkinson's disease for 10–15 years.